Avanos Medical, Inc.
AVNS
$12.15
-$0.56-4.41%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -384.60M | -392.10M | 15.70M | 11.40M | -58.50M |
| Total Depreciation and Amortization | 43.70M | 45.50M | 45.90M | 34.20M | 34.40M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 412.90M | 412.30M | 9.80M | 6.50M | 67.50M |
| Change in Net Operating Assets | 62.40M | 35.00M | -15.90M | -19.60M | -41.30M |
| Cash from Operations | 134.40M | 100.70M | 55.50M | 61.60M | 31.20M |
| Capital Expenditure | -20.40M | -17.80M | -18.90M | -15.90M | -14.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -2.10M | -2.10M | -4.60M |
| Divestitures | 0.00 | 2.10M | 91.10M | 91.10M | 91.10M |
| Other Investing Activities | -14.20M | -11.80M | -9.00M | -- | -- |
| Cash from Investing | -34.60M | -27.50M | 61.10M | 24.20M | 23.60M |
| Total Debt Issued | 0.00 | 20.00M | 20.00M | 20.00M | 20.00M |
| Total Debt Repaid | -69.30M | -53.60M | -122.90M | -109.70M | -109.70M |
| Issuance of Common Stock | 1.00M | 1.10M | 1.10M | 500.00K | 500.00K |
| Repurchase of Common Stock | -5.90M | -12.80M | -19.10M | -19.00M | -18.10M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.30M | -3.80M | -15.50M | -12.20M | -12.20M |
| Cash from Financing | -77.50M | -49.10M | -136.40M | -73.70M | -72.80M |
| Foreign Exchange rate Adjustments | -1.10M | -4.10M | 1.70M | -100.00K | -300.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 21.20M | 20.00M | -18.10M | 10.40M | -19.90M |